Details of the Drug

General Information of Drug (ID: DMZNGI9)

• Drug Name: INKmune

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DJ9H4F

References

• [1] Clinical pipeline report, company report or official report of INmune Bio